PubMed

Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes.

Navaratna D, McGuire PG, Menicucci G, Das A.

Diabetes. 2007 Sep;56(9):2380-7. Epub 2007 May 29.PMID: 17536065 [PubMed - indexed for MEDLINE]Related articlesFree article

A peptide inhibitor of the urokinase/urokinase receptor system inhibits alteration of the blood-retinal barrier in diabetes.

Navaratna D, Menicucci G, Maestas J, Srinivasan R, McGuire P, Das A.

FASEB J. 2008 Sep;22(9):3310-7. Epub 2008 Jun 16.PMID: 18559877 [PubMed - indexed for MEDLINE]Related articlesFree article

Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier.

Giebel SJ, Menicucci G, McGuire PG, Das A.

Lab Invest. 2005 May;85(5):597-607.PMID: 15711567 [PubMed - indexed for MEDLINE]Related articlesFree article

Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown.

Skondra D, Noda K, Almulki L, Tayyari F, Frimmel S, Nakazawa T, Kim IK, Zandi S, Thomas KL, Miller JW, Gragoudas ES, Hafezi-Moghadam A.

Invest Ophthalmol Vis Sci. 2008 Feb;49(2):726-31.PMID: 18235021 [PubMed - indexed for MEDLINE]Related articlesFree article

Albumin-derived advanced glycation end-products trigger the disruption of the vascular endothelial cadherin complex in cultured human and murine endothelial cells.

Otero K, Martínez F, Beltrán A, González D, Herrera B, Quintero G, Delgado R, Rojas A.

Biochem J. 2001 Nov 1;359(Pt 3):567-74.PMID: 11672430 [PubMed - indexed for MEDLINE]Related articlesFree article

Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes.

Zhang J, Wu Y, Jin Y, Ji F, Sinclair SH, Luo Y, Xu G, Lu L, Dai W, Yanoff M, Li W, Xu GT.

Invest Ophthalmol Vis Sci. 2008 Feb;49(2):732-42.PMID: 18235022 [PubMed - indexed for MEDLINE]Related articlesFree article

TGF-beta increases retinal endothelial cell permeability by increasing MMP-9: possible role of glial cells in endothelial barrier function.

Behzadian MA, Wang XL, Windsor LJ, Ghaly N, Caldwell RB.

Invest Ophthalmol Vis Sci. 2001 Mar;42(3):853-9.PMID: 11222550 [PubMed - indexed for MEDLINE]Related articlesFree article

Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group.

Antonetti DA, Barber AJ, Khin S, Lieth E, Tarbell JM, Gardner TW.

Diabetes. 1998 Dec;47(12):1953-9.PMID: 9836530 [PubMed - indexed for MEDLINE]Related articlesFree article

Suppression of retinal neovascularization with an antagonist to vascular endothelial cadherin.

Navaratna D, Maestas J, McGuire PG, Das A.

Arch Ophthalmol. 2008 Aug;126(8):1082-8.PMID: 18695103 [PubMed - indexed for MEDLINE]Related articlesFree article

Advanced glycation end products induce blood-retinal barrier dysfunction in normoglycemic rats.

Stitt AW, Bhaduri T, McMullen CB, Gardiner TA, Archer DB.

Mol Cell Biol Res Commun. 2000 Jun;3(6):380-8.PMID: 11032761 [PubMed - indexed for MEDLINE]Related articles

Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.

Kusari J, Zhou S, Padillo E, Clarke KG, Gil DW.

Invest Ophthalmol Vis Sci. 2007 Nov;48(11):5152-9.PMID: 17962468 [PubMed - indexed for MEDLINE]Related articlesFree article

VEGF164 is proinflammatory in the diabetic retina.

Ishida S, Usui T, Yamashiro K, Kaji Y, Ahmed E, Carrasquillo KG, Amano S, Hida T, Oguchi Y, Adamis AP.

Invest Ophthalmol Vis Sci. 2003 May;44(5):2155-62.PMID: 12714656 [PubMed - indexed for MEDLINE]Related articlesFree article

The role of adherens junctions and VE-cadherin in the control of vascular permeability.

Dejana E, Orsenigo F, Lampugnani MG.

J Cell Sci. 2008 Jul 1;121(Pt 13):2115-22. Review.PMID: 18565824 [PubMed - indexed for MEDLINE]Related articlesFree article

Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.

Leal EC, Manivannan A, Hosoya K, Terasaki T, Cunha-Vaz J, Ambrósio AF, Forrester JV.

Invest Ophthalmol Vis Sci. 2007 Nov;48(11):5257-65.PMID: 17962481 [PubMed - indexed for MEDLINE]Related articlesFree article

Permeability of the blood-retinal and blood-aqueous barriers in galactose-fed rats.

Caspers-Velu LE, Wadhwani KC, Rapoport SI, Kador PF.

J Ocul Pharmacol Ther. 1995 Fall;11(3):469-87.PMID: 8590278 [PubMed - indexed for MEDLINE]Related articles

Blood-retinal barrier breakdown induced by activation of protein kinase C via vascular endothelial growth factor in streptozotocin-induced diabetic rats.

Xu X, Zhu Q, Xia X, Zhang S, Gu Q, Luo D.

Curr Eye Res. 2004 Apr;28(4):251-6.PMID: 15259294 [PubMed - indexed for MEDLINE]Related articles

Electron microscopic immunocytochemical evidence for the mechanism of blood-retinal barrier breakdown in galactosemic rats and its association with aldose reductase expression and inhibition.

Vinores SA, Van Niel E, Swerdloff JL, Campochiaro PA.

Exp Eye Res. 1993 Dec;57(6):723-35.PMID: 8150024 [PubMed - indexed for MEDLINE]Related articles

MMP9 is involved in glycation end-products induced increase of retinal vascular permeability in rats and the therapeutic effect of minocycline.

Chen YD, Xu X, Xia X, Wu H, Liu K, Zheng Z, Zhu D.

Curr Eye Res. 2008 Nov;33(11):977-83.PMID: 19085380 [PubMed - indexed for MEDLINE]Related articles

Human Schlemm's canal cells express the endothelial adherens proteins, VE-cadherin and PECAM-1.

Heimark RL, Kaochar S, Stamer WD.

Curr Eye Res. 2002 Nov;25(5):299-308.PMID: 12658549 [PubMed - indexed for MEDLINE]Related articles

Reduced expression of the adherens junction protein cadherin-5 in a diabetic retina.

Davidson MK, Russ PK, Glick GG, Hoffman LH, Chang MS, Haselton FR.

Am J Ophthalmol. 2000 Feb;129(2):267-9.PMID: 10682990 [PubMed - indexed for MEDLINE]Related articles